SIEVF yields 0.98% · JNJ yields 2.13%● Live data
📍 SIEVF pulled ahead of the other in Year 1
Combined, SIEVF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SIEVF + JNJ for your $10,000?
D'Ieteren Group SA, operates as an investment company worldwide. The company operates through D'Ieteren Automotive, Belron, Moleskine, and TVH Parts segments. It distributes Volkswagen, Audi, SEAT, KODA, Cupra, Bentley, Lamborghini, Bugatti, and Porsche brand vehicles, as well as its spare parts and accessories; sells used vehicles; and offers maintenance, financing, and leasing services. The company also provides vehicle glass repair, replacement, and recalibration services under the Carglass, Safelite, and Autoglass brand names; and manages vehicle glass and other insurance claims on behalf of insurance customers. In addition, it offers notebooks, planners, writing tools, bags, and reading accessories, as well as smart writing system and mobile apps. Further, the company distributes aftermarket parts for material handling, construction, and agricultural & industrial equipment. Additionally, it manages real estate assets, including offices, workshops, concessions, logistics centers, residential units, parking lots, and landbanks; reconverts and redevelops sites; and offers real estate advice. The company was founded in 1805 and is headquartered in Brussels, Belgium.
Full SIEVF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.